References

1. Armenian SH. Anthracycline-Induced Cardiotoxicity in Young Cancer Patients: The Role of Carnitine. Ann Nutr Metab. 2016;68 Suppl 3:10-14. doi:10.1159/000448322

2. de Azambuja E. Cardiotoxicity in Oncology Practice. European Society for Medical Oncology. Published 2011. Accessed October 5, 2019. https://www.esmo.org/education/oncology-in-practice/cardiotoxicity

3. Stenger M. ASCO Clinical Practice Guideline on Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers. The ASCO Post. April 10, 2017. Accessed June 3, 2025. https://ascopost.com/issues/april-10-2017/asco-clinical-practice-guideline-on-prevention-and-monitoring-of-cardiac-dysfunction-in-survivors-of-adult-cancers/

4. Asnani A, Neilan T, Tripathy D, Scherrer-Crosbie, M. Clinical manifestations, monitoring, and diagnosis of anthracycline-induced cardiotoxicity. July 17, 2019. Viewed October 5, 2019.

5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Survivorship. Version 2.2025. ©2025. Accessed June 4, 2025. https://www.nccn.org

6. Friedman DL, Hudson MM, Landier W. Heart Health: Keeping Your Heart Healthy After Treatment for Childhood Cancer. Children’s Oncology Group. Version 4.0. http://survivorshipguidelines.org/pdf/healthlinks/English/heart_health_Eng.pdf. Published 2018. Accessed October 5, 2019.

7. Witt CM, Balneaves LG, Cardoso MJ, et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017;2017(52):10.1093/jncimonographs/lgx012. doi:10.1093/jncimonographs/lgx012

8. Guasch-Ferré M, Salas-Salvadó J, Ros E, et al. The PREDIMED trial, Mediterranean diet and health outcomes: How strong is the evidence?. Nutr Metab Cardiovasc Dis. 2017;27(7):624-632. doi:10.1016/j.numecd.2017.05.004

9. Lichtenstein AH, Appel LJ, Vadiveloo M, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144(23):e472-e487. doi:10.1161/CIR.0000000000001031

10. Gardner CD, Vadiveloo MK, Petersen KS, et al. Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association. Circulation. 2023;147(22):1715-1730. doi:10.1161/CIR.0000000000001146

11. Writing Committee Members, Virani SS, Newby LK, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2023 Oct 31;82(18):1808. doi: 10.1016/j.jacc.2023.09.794.] [published correction appears in J Am Coll Cardiol. 2024 Apr 30;83(17):1716. doi: 10.1016/j.jacc.2024.03.399.]. J Am Coll Cardiol. 2023;82(9):833-955. doi:10.1016/j.jacc.2023.04.003

12. Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70(4):245-271. doi:10.3322/caac.21591

13. Ubago-Guisado E, Rodríguez-Barranco M, Ching-López A, et al. Evidence Update on the Relationship between Diet and the Most Common Cancers from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: A Systematic Review. Nutrients. 2021;13(10):3582. Published 2021 Oct 13. doi:10.3390/nu13103582

14. Alizadehasl A, Malekzadeh Moghani M, Mirzaei H, et al. Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial. J Integr Complement Med. 2024;30(10):995-1001. doi:10.1089/jicm.2023.0777

15. Barone Gibbs B, Hivert MF, Jerome GJ, et al. Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension. 2021;78(2):e26-e37. doi:10.1161/HYP.0000000000000196

16. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11(11):CD006145. Published 2012 Nov 14. doi:10.1002/14651858.CD006145.pub3

17. Dozic S, Howden EJ, Bell JR, Mellor KM, Delbridge LMD, Weeks KL. Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy. Cells. 2023;12(9):1312. Published 2023 May 4. doi:10.3390/cells12091312

18. Hornsby WE, Douglas PS, West MJ, et al. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. Acta Oncol. 2014;53(1):65-74. doi:10.3109/0284186X.2013.781673

19. Jones LW, Habel LA, Weltzien E, et al. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016;34(23):2743-2749. doi:10.1200/JCO.2015.65.6603

20. Segal R, Zwaal C, Green E, et al. Exercise for people with cancer: a clinical practice guideline. Curr Oncol. 2017;24(1):40-46. doi:10.3747/co.24.3376

21. Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise Therapy and Cardiovascular Toxicity in Cancer. Circulation. 2018;137(11):1176-1191. doi:10.1161/CIRCULATIONAHA.117.024671

22. Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association. Circulation. 2021;143(10):e763-e783. doi:10.1161/CIR.0000000000000947

23. Twohig-Bennett C, Jones A. The health benefits of the great outdoors: A systematic review and meta-analysis of greenspace exposure and health outcomes. Environ Res. 2018;166:628-637. doi:10.1016/j.envres.2018.06.030

24. Rojas-Rueda D, Nieuwenhuijsen MJ, Gascon M, Perez-Leon D, Mudu P. Green spaces and mortality: a systematic review and meta-analysis of cohort studies [published correction appears in Lancet Planet Health. 2021 Aug;5(8):e504. doi: 10.1016/S2542-5196(21)00208-4.]. Lancet Planet Health. 2019;3(11):e469-e477. doi:10.1016/S2542-5196(19)30215-3

25. Pole L, Hepp N. Sourcing Quality Supplements at a Glance. CancerChoices. Updated June 4, 2023. Accessed June 3, 2025. https://cancerchoices.org/resources/reviews-of-complementary-therapies/sourcing-quality-herbs-supplements/

26. El Amrousy D, El-Afify D, Khedr R, Ibrahim AM. Omega 3 fatty acids can reduce early doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2022;69(7):e29496. doi:10.1002/pbc.29496

27. Hagag AA, El Shehaby WA, El-Abasy AI, Mabrouk MM. Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia. Infect Disord Drug Targets. 2019;19(2):133-140. doi:10.2174/1871526518666180803141827

28. Gurley BJ, Swain A, Hubbard MA, et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res. 2008;52(7):755-763. doi:10.1002/mnfr.200600300

29. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto [published correction appears in Clin Pharmacol Ther. 2005 May;77(5):456]. Clin Pharmacol Ther. 2004;76(5):428-440. doi:10.1016/j.clpt.2004.07.007

30. Fuhr U, Beckmann-Knopp S, Jetter A, Lück H, Mengs U. The effect of silymarin on oral nifedipine pharmacokinetics. Planta Med. 2007;73(14):1429-1435. doi:10.1055/s-2007-990256

31. Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients. Cancer Treat Rev. 2013;39(7):773-783. doi:10.1016/j.ctrv.2012.12.008

32. Moreno-Vega A, Vega-Riveroll L, Ayala T, et al. Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study. Nutrients. 2019;11(7):1623. Published 2019 Jul 17. doi:10.3390/nu11071623

33. Cao S, Xue J, Chen L, et al. Effects of the Chinese herbal medicine Hong Huang decoction, on myocardial injury in breast cancer patients who underwent anthracycline-based chemotherapy. Front Cardiovasc Med. 2022;9:921753. Published 2022 Jul 22. doi:10.3389/fcvm.2022.921753

34. Hamidian M, Foroughinia F, Haghighat S, Attar A, Haem E. Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial. J Oncol Pharm Pract. 2023;29(6):1306-1316. doi:10.1177/10781552221118530

35. Kim MG, Kim Y, Jeon JY, Kim DS. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach. Br J Clin Pharmacol. 2016;82(6):1580-1590. doi:10.1111/bcp.13080

36. Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol. 2003;43(6):643-648.

37. Gurley BJ, Gardner SF, Hubbard MA, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther. 2002;72(3):276-287. doi:10.1067/mcp.2002.126913

38. Malati CY, Robertson SM, Hunt JD, et al. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J Clin Pharmacol. 2012;52(6):932-939. doi:10.1177/0091270011407194

39. Hagag AA, Badraia IM, El-Shehaby WA, Mabrouk MM. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia. J Oncol Pharm Pract. 2020;26(6):1397-1406. doi:10.1177/1078155219897294

40. Yi SY, et al. Chinese Journal of Integrated Traditional and Western Medicine. 2008;28(1):68-70.

41. Wolf HR. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?. Drugs R D. 2006;7(3):163-172. doi:10.2165/00126839-200607030-00003

42. Gardner CD, Zehnder JL, Rigby AJ, Nicholus JR, Farquhar JW. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis. 2007;18(8):787-793. doi:10.1097/MBC.0b013e3282f102b1

43. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502. doi:10.1592/phco.31.5.490

44. Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-661. doi:10.1111/j.1525-1497.2005.0121.x

45.  Iarussi D, Auricchio U, Agretto A, et al. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Mol Aspects Med. 1994;15 Suppl:s207-s212. doi:10.1016/0098-2997(94)90030-2

46. Takimoto M, et al. Gan to Kagaku Ryoho. 1982;9(1):116-121.

47. Okuma K, et al. Gan to Kagaku Ryoho. 1984;11(3):502-508.

48. Hao W, Shi YY, Qin YN, et al. Cardioprotective effect of Chinese herbal medicine for anthracycline-induced cardiotoxicity in cancer patients: A meta-analysis of prospective studies. Medicine (Baltimore). 2022;101(30):e29691. Published 2022 Jul 29. doi:10.1097/MD.0000000000029691

49. Yang J, Wang F, Wang Z, Wang L. Systematic Assessment of Chinese Medicine Compounds for Mitigating Anthracycline-Induced Cardiotoxicity. Altern Ther Health Med. 2024;30(11):404-409.

50. Gray B, Ingles J, Medi C, Driscoll T, Semsarian C. Cardiovascular Effects of Energy Drinks in Familial Long QT Syndrome: A Randomized Cross-Over Study. Int J Cardiol. 2017;231:150-154. doi:10.1016/j.ijcard.2016.12.019